Brief: Cosciens Biopharma Inc. Provides Updates On Merger Integration, Management Succession Plans And Ongoing Development Programs
23/09/2024 14:17
Sept 23 (Reuters) - COSCIENS Biopharma Inc CSCI.TO :
* COSCIENS BIOPHARMA INC. PROVIDES UPDATES ON MERGER
INTEGRATION,
MANAGEMENT SUCCESSION PLANS AND ONGOING DEVELOPMENT PROGRAMS
* COSCIENS BIOPHARMA INC - ELIMINATES MANAGERIAL AND
TECHNICAL
POSITIONS FOR COST REDUCTION
* COSCIENS BIOPHARMA INC - DISCONTINUES SPEND ON MACIMORELIN
ALS
PROGRAM
* COSCIENS BIOPHARMA: DOES NOT HAVE SUFFICIENT CONFIDENCE
FROM
DATA OBTAINED TO PROVIDE MUCH NEEDED TREATMENT FOR ALS PATIENTS
THAT IT ONCE HOPED
Source text for Eikon: ID:nGNX71k8md
Further company coverage: CSCI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update